Creyon Bio, Inc. – Trademark Portfolio
Entity Type: 03
Creyon Bio, Inc. has 6 U.S. trademark filings recorded with the United States Patent and Trademark Office (USPTO). Of these, 3 are successfully registered — a 50% registration rate. The portfolio includes marks such as CREYON. Filings span 4 Nice Classification classes, with the highest activity in Class 42 (Computer & Scientific) and Class 44 (Medical Services). This trademark owner is based in San Diego, CA.
3210 Merryfield Row
San Diego, CA 92121
Showing of trademarks Trademarks
Trademark Classifications
Creyon Bio, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific and technological services; industrial analysis and research services
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does Creyon Bio, Inc. have?
Creyon Bio, Inc. has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 3 abandoned.
What trademark classes does Creyon Bio, Inc. file in?
Creyon Bio, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 1 (Chemicals), Class 5 (Pharmaceuticals). Class 42 covers scientific and technological services; industrial analysis and research services.
What are Creyon Bio, Inc.'s most well-known trademarks?
Creyon Bio, Inc.'s registered trademark portfolio includes well-known marks such as CREYON. These are among 3 currently registered trademarks in the portfolio.
What is Creyon Bio, Inc.'s trademark registration success rate?
Creyon Bio, Inc. has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.